Latest Impairment News

Turners Automotive Group has raised its net profit guidance for FY26 to $63 million, driven by robust vehicle sales and record finance lending, despite a goodwill write-down in its EC Credit division.

Image Resources NL is set to record significant non-cash impairments totalling around A$61 million in its 2025 financial results, reflecting challenges from weaker mineral sands prices and a stronger Australian dollar.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

Novo Resources has completed the first tranche of a capital raising, securing A$6.2 million, while announcing significant valuation impairments ahead of its 2025 financial report.

Bapcor Limited has initiated a fully underwritten $200 million equity raising at $0.60 per share, aiming to reduce debt and support a strategic turnaround under new leadership. The retail entitlement offer opened on 5 March and closes on 19 March 2026.

MCS Services Limited reported a 32% revenue decline for the half-year ending December 2025, alongside improved EBITDA and no significant impairments. The company is moving forward with a proposed sale of its Highways Traffic business, though an auditor’s going concern warning casts a shadow over its near-term outlook.

Peak Processing Limited reported a sharp 47.7% revenue drop and a 257.7% increase in losses for H1 2026, alongside a significant asset impairment and ongoing going concern concerns.

Vmoto Limited reported an 18% revenue decline to $46.8 million and a $9.9 million net loss in FY25, while accelerating its transformation into a full-stack electric mobility solutions provider with new global partnerships and product innovations.

Argent BioPharma reported a significantly reduced half-year loss of A$2.9 million, progressing a strategic acquisition to bolster its CannEpil drug pipeline and securing up to A$11 million in new funding.

TerraCom Limited reported a significant half-year loss amid falling coal prices and production challenges, completing a $56 million capital raise to strengthen its financial position.

HALO Technologies reports a strategic pivot towards APAC growth and a UK business model overhaul, alongside a 16% revenue decline and increased net loss in FY25.

Halo Technologies Holdings Ltd posted a $17.4 million loss for 2025, widening from $14.5 million the previous year, as revenue fell 16%. The company completed a $3.9 million rights issue and announced a strategic pivot in its UK operations.